Everest Med (HKEX: 01952) has announced that its board was informed by Mr. Fu Wei, a non-executive director, honorary chairman of the board, and a major shareholder, that between June 16, 2026, and June 17, 2026, CBC Group, acting as a principal shareholder, acquired 712,000 ordinary shares of the company on the market.

The total consideration for the transaction was approximately HK$19.2 million, with an average price of about HK$26.99 per share.

Since December 2025, CBC Group and the director have collectively purchased over 5.163 million shares on the market, with a total consideration exceeding HK$172.5 million.

The board views these share purchases as a reflection of the strong confidence that the company's directors and major shareholders have in its future prospects and long-term development.

Subject to compliance with applicable laws and regulations, CBC Group and the director do not rule out the possibility of further increasing their stakes in the company at an appropriate time.